Glutathione synthesis is diminished in patients with uncontrolled diabetes and restored by dietary supplementation with cysteine and glycine

Diabetes Care

Volumn 34, Issue 1, 2011, Pages 162-167

  Sekhar, Rajagopal V ^a   Mckay, Siripoom V ^a   Patel, Sanjeet G ^a   Guthikonda, Anuradha P ^a   Reddy, Vasumathi T ^a   Balasubramanyam, Ashok ^a   Jahoor, Farook ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CREATININE; CYSTEINE; GLUCOSE; GLUTAMIC ACID; GLUTATHIONE; GLYCINE; HEMOGLOBIN; HEMOGLOBIN A1C; LIPID PEROXIDE; REACTIVE OXYGEN METABOLITE; UREA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC PATIENT; DIET RESTRICTION; DIET SUPPLEMENTATION; ERYTHROCYTE; GLUCOSE BLOOD LEVEL; GLUTATHIONE METABOLISM; HEMOGLOBIN BLOOD LEVEL; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; UREA NITROGEN BLOOD LEVEL;

CYSTEINE; DIABETES MELLITUS, TYPE 2; DIETARY SUPPLEMENTS; FEMALE; GLUTATHIONE; GLYCINE; HUMANS; MALE; MIDDLE AGED;

EID: 79951696287     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc10-1006     Document Type: Article

References (23)

1. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001;414:813-820 (Pubitemid 34000785)
2. Whiting PH, Kalansooriya A, Holbrook I, Haddad F, Jennings PE. The relationship between chronic glycaemic control and oxidative stress in type 2 diabetes mellitus. Br J Biomed Sci 2008;65:71-74 (Pubitemid 351913978)
3. Sundaram RK, Bhaskar A, Vijayalingam S, Viswanathan M, Mohan R, Shanmugasundaram KR. Antioxidant status and lipid peroxidation in type II diabetes mellitus with and without complications. Clin Sci (Lond) 1996;90:255-260 (Pubitemid 26097891)
4. Vijayalingam S, Parthiban A, Shanmugasundaram KR, Mohan V. Abnormal antioxidant status in impaired glucose tolerance and non-insulin-dependent diabetes mellitus. Diabet Med 1996;13:715-719 (Pubitemid 26252949)
5. Memisogullari R, Taysi S, Bakan E, Capoglu I. Antioxidant status and lipid peroxidation in type II diabetes mellitus. Cell Biochem Funct 2003;21:291-296 (Pubitemid 36988384)
6. Menon V, Ram M, Dorn J, Armstrong D, Muti P, Freudenheim JL, Browne R, Schunemann H, Trevisan M. Oxidative stress and glucose levels in a population-based sample. Diabet Med 2004;21:1346-1352 (Pubitemid 39620060)
7. Bravi MC, Armiento A, Laurenti O, Cassone-Faldetta M, De Luca O, Moretti A, De Mattia G. Insulin decreases intracellular oxidative stress in patients with type 2 diabetes mellitus. Metabolism 2006;55: 691-695 (Pubitemid 44316511)
8. Unger J. Reducing oxidative stress in patients with type 2 diabetes mellitus: a primary care call to action. Insulin 2008;3: 176-184
9. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329: 977-986
10. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352:837-853,
11. Fan T, Koro CE, Fedder DO, Bowlin SJ. Ethnic disparities and trends in glycemic control among adults with type 2 diabetes in the U.S. from 1988 to 2002. Diabetes Care 2006;29:1924-1925
12. Reid M, Jahoor F. Methods for measuring glutathione concentration and rate of synthesis. Curr Opin Clin Nutr Metab Care 2000;3:385-390
13. Nourooz-Zadeh J. Ferrous ion oxidation in presence of xylenol orange for detection of lipid hydroperoxides in plasma. Methods Enzymol 1999;300:58-62
14. De Luca G, Calpona PR, Caponetti A, Macaione V, Di Benedetto A, Cucinotta D, Di Giorgio RM. Preliminary report: amino acid profile in platelets of diabetic patients. Metabolism 2001;50:739-741 (Pubitemid 32700450)
15. Gougeon R, Morais JA, Chevalier S, Pereira S, Lamarche M, Marliss EB. Determinants of whole-body protein metabolism in subjects with and without type 2 diabetes. Diabetes Care 2008;31:128-133
16. Lyons J, Rauh-Pfeiffer A, Yu YM, Lu XM, Zurakowski D, Tompkins RG, Ajami AM, Young VR, Castillo L. Blood glutathione synthesis rates in healthy adults receiving a sulfur amino acid-free diet. Proc Natl Acad Sci U S A 2000;97:5071-5076 (Pubitemid 30313673)
17. Jackson AA, Gibson NR, Lu Y, Jahoor F. Synthesis of erythrocyte glutathione in healthy adults consuming the safe amount of dietary protein. Am J Clin Nutr 2004;80:101-107 (Pubitemid 41115562)
18. Grimble RF, Jackson AA, Persaud C, Wride MJ, Delers F, Engler R. Cysteine and glycine supplementation modulate the metabolic response to tumor necrosis factor alpha in rats fed a low protein diet. J Nutr 1992;122:2066-2073
19. Jahoor F, Wykes LJ, Reeds PJ, Henry JF, del Rosario MP, Frazer ME. Protein-deficient pigs cannot maintain reduced glutathione homeostasis when subjected to the stress of inflammation. J Nutr 1995;125: 1462-1472
20. Bella DL, Hahn C, Stipanuk MH. Effects of nonsulfur and sulfur amino acids on the regulation of hepatic enzymes of cysteine metabolism. Am J Physiol 1999; 277:E144-E153 (Pubitemid 29356738)
21. Cresenzi CL, Lee JI, Stipanuk MH. Cysteine is the metabolic signal responsible for dietary regulation of hepatic cysteine dioxygenase and glutamate cysteine ligase in intact rats. J Nutr 2003;133: 2697-2702 (Pubitemid 37099747)
22. Nishikawa T, Edelstein D, Brownlee M. The missing link: a single unifying mechanism for diabetic complications. Kidney Int Suppl 2000;77:S26-S30
23. Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, Giardino I, Brownlee M. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 2000;404:787-790 (Pubitemid 30212409)